路透9月14日 - Contineum Therapeutics(CTNM.O)周一表示,该公司与强生公司(JNJ.N)联合研发的一种抗抑郁试验性药物未能达到中期临床试验的主要目标。
路透9月14日 - Contineum Therapeutics(CTNM.O)周一表示,该公司与强生公司(JNJ.N)联合研发的一种抗抑郁试验性药物未能达到中期临床试验的主要目标。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.